| 前收市價 | 9.50 |
| 開市 | 9.50 |
| 買盤 | 6.00 |
| 賣出價 | 8.80 |
| 拍板 | 18.00 |
| 到期日 | 2024-08-16 |
| 今日波幅 | 9.50 - 9.50 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 150 |
ZacksCorcept (CORT) Shares Rise 20% in Three Months: Here's Why
Corcept's (CORT) pipeline progress has been encouraging with relacorilant currently under evaluation for Cushing's syndrome. The NDA for relacorilant is expected to be filed in the third quarter.
Insider MonkeyWhat Makes Corcept Therapeutics (CORT) a Good Investment Bet?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Value Strategy” first quarter 2024 investor letter. A copy of the letter can be downloaded here. The firm focuses on companies with strong balance sheets and attractive cash flows with compelling valuations rather than following market trends. The strategy outperformed the benchmark Russell 2000 Value […]
ZacksCorcept Therapeutics (CORT) is a Top-Ranked Momentum Stock: Should You Buy?
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
